Search results
In June 2012, the FDA approved a combination vaccine against two types of meningococcal disease and Hib disease for infants and children 6 weeks to 18 months old. The vaccine, Menhibrix, prevents disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.
24 paź 2024 · MenABCWY vaccine (Penbraya™) helps protect against 5 serogroups of the bacteria that cause meningococcal disease: A, B, C, W, and Y. This type of vaccine is also known as a serogroup A, B, C, W, and Y, or pentavalent, meningococcal vaccine.
26 sty 2022 · Meningococcal vaccines protect against various serotypes, or distinguishable strains, of Neisseria meningitidis. This bacterial strain can cause serious infections including meningitis ...
4 kwi 2014 · Nimenrix is a vaccine used to protect adults, adolescents and children from the age of 6 weeks against invasive meningococcal disease caused by four groups of the bacterium Neisseria meningitidis (group A, C, W-135, and Y).
Currently, there are 6 meningococcal vaccines licensed and available in the United States. Learn about the composition, types, immunogenicity, and effectiveness of these vaccines, as well as view package inserts, below.
26 cze 2024 · Key points. CDC recommends meningococcal vaccination for all preteens and teens, as well as other children and adults at increased risk. Meningococcal vaccines are the best way to protect against meningococcal disease, but side effects can occur. Talk to a vaccine provider if you have questions about meningococcal vaccines. Overview.
Meningococcal meningitis is an epidemic-prone disease and there is a global emergency meningococcal vaccine stockpile managed through the International Coordinating Group (ICG) for vaccine provision for meningococcal meningitis. Defeating meningitis by 2030.
